@article{Romanov_2020,<br/><span class="tab"></span> title={Safety of Hydroxychloroquine,<br/><span class="tab"></span> Favipiravir,<br/><span class="tab"></span> and the Combination of Lopinavir and Ritonavir in the Treatment of the “First Wave” of the New Coronavirus Infection COVID-19},<br/><span class="tab"></span> volume={10},<br/><span class="tab"></span> ISSN={1991-2919},<br/><span class="tab"></span> url={http://dx.doi.org/10.30895/1991-2919-2020-10-3-148-151},<br/><span class="tab"></span> DOI={10.30895/1991-2919-2020-10-3-148-151},<br/><span class="tab"></span> number={3},<br/><span class="tab"></span> journal={The Bulletin of the Scientific Centre for Expert Evaluation of Medicinal Products},<br/><span class="tab"></span> publisher={SCEEMP},<br/><span class="tab"></span> author={Romanov,<br/><span class="tab"></span> B. K.},<br/><span class="tab"></span> year={2020},<br/><span class="tab"></span> month=sep,<br/><span class="tab"></span> pages={148–151} }